814 results on '"Gabelle, Audrey"'
Search Results
2. Monitoring synaptic pathology in Alzheimer’s disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives
3. Brain MRI to PET Synthesis and Amyloid Estimation in Alzheimer’s Disease via 3D Multimodal Contrastive GAN
4. CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
5. Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations
6. Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening
7. Comparison of ultrasensitive and mass spectrometry quantification of blood-based amyloid biomarkers for Alzheimer’s disease diagnosis in a memory clinic cohort
8. Brain MRI to PET Synthesis and Amyloid Estimation in Alzheimer’s Disease via 3D Multimodal Contrastive GAN
9. A critical appraisal of blood-based biomarkers for Alzheimer’s disease
10. Socioeconomic inequalities in dementia risk among a French population-based cohort: quantifying the role of cardiovascular health and vascular events
11. Forecasting the Prevalence of Alzheimer’s Disease at Mild Cognitive Impairment and Mild Dementia Stages in France in 2022
12. Effects of physical activity and exercise interventions on Alzheimer’s disease: an umbrella review of existing meta-analyses
13. Cross-sectional associations between cortical thickness and physical activity in older adults with spontaneous memory complaints: The MAPT Study
14. Neural correlates of episodic memory in the Memento cohort
15. Modeling the Simultaneous Dynamics of Proteins in Blood Plasma and the Cerebrospinal Fluid in Human In Vivo
16. Sulcal morphology as cognitive decline predictor in older adults with memory complaints
17. Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
18. Explaining the association between social and lifestyle factors and cognitive functions: a pathway analysis in the Memento cohort
19. Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort
20. The interplay between cognition, depression, anxiety, and sleep in primary Sjogren’s syndrome patients
21. Complaints of daytime sleepiness, insomnia, hypnotic use, and risk of dementia: a prospective cohort study in the elderly
22. Enabling population protein dynamics through Bayesian modeling.
23. Association of caffeine consumption with memory deficits and cerebrospinal fluid biomarkers in Mild Cognitive Impairment and Alzheimer's Disease: a BALTAZAR cohort study
24. Intuition Brain Health Study: a smartphone- and smartwatch-based virtual, observational study using multimodal mobile sensing to classify and detect mild cognitive impairment
25. Plasma p-tau181 as an outcome and predictor of multidomain intervention effects: a secondary analysis of a randomised, controlled, dementia prevention trial
26. Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations
27. Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment
28. Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum
29. The association between Aβ aggregation and age depends on APOE genotype: Findings from the AMYPAD cohort
30. Immunoassay and Mass Spectrometry Methods for Tau Protein Quantification in the Cerebrospinal Fluid
31. Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials
32. Association of Long-Term Diet Quality with Hippocampal Volume: Longitudinal Cohort Study
33. Precision medicine analysis of heterogeneity in individual‐level treatment response to amyloid beta removal in early Alzheimer's disease.
34. Precision medicine analysis of heterogeneity in individual‐level treatment response to amyloid beta removal in early Alzheimer's disease
35. Head-to-Head Comparison of Two Plasma Phospho-tau Assays in Predicting Conversion of Mild Cognitive Impairment to Dementia
36. Imagerie métabolique et moléculaire : l’exemple des maladies neurodégénératives
37. Red blood cell membrane omega-3 fatty acid levels and physical performance: Cross-sectional data from the MAPT study
38. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers
39. Sex-specific association between neighborhood characteristics and dementia: The Three-City cohort
40. Towards a routine application of Top-Down approaches for label-free discovery workflows
41. SILK studies — capturing the turnover of proteins linked to neurodegenerative diseases
42. Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
43. Cerebrospinal fluid levels of orexin-A and histamine, and sleep profile within the Alzheimer process
44. Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
45. Influence of activity space on the association between neighborhood characteristics and dementia risk: results from the 3-City study cohort
46. Sex-specific depressive symptoms as markers of pre-Alzheimer dementia: findings from the Three-City cohort study
47. Stable Isotope Labeling Kinetics in CNS Translational Medicine: Introduction to SILK Technology
48. Analysis of Psychological Symptoms Following Disclosure of Amyloid-Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline
49. Cognitive Health in Underrepresented Populations—Early Learnings From INTUITION: A Brain Health Study (P14-6.009)
50. Reliability of Unsupervised Digital Cognitive Assessment in a Large Adult Population Across the Aging Lifespan from INTUITION: A Brain Health Study (S8.009)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.